October 7, 2021

ImmuneWatch selected for “Innovative ideas” pitch

We are happy to announce that we have been selected to pitch our startup at “Immunity for Health 2021” in Ghent on October 14, 2021.

Our talk, given by our CEO Sander, has been selected for the “innovative ideas” section in the morning session.

Registration is still possible here.

See you there?

Stay up to date

Subscribe to our newsletter to receive useful tips and information.

Thank you! Your submission has been received!

Oups ! Un problème s'est produit lors de l'envoi du formulaire.

Recommended articles

April 5, 2024

Launching the ImmuneWatch DETECT Early Access Program

Are you ready to change the way you interpret your TCR sequencing data? We’re thrilled to announce the launch of our ImmuneWatch DETECT Early Access Program – a unique opportunity for innovators that are using TCR sequencing.

March 22, 2024

ImmuneWatch releases white paper evaluating the effect of mutations gathered in the SARS-COV-2 Omicron variant on T cell immunity

Omicron, the latest SARS-COV-2 variant of concern is characterized by a large number of mutations. In our first white paper, we evaluate the effect of these mutations on T-cell immunity by applying a T-cell receptor (TCR)/epitope interaction model.